Fagron TrichoTest™ is a genetic hair loss test that analyzes gene variations and lifestyle factors to accurately recommend personalized hair loss treatment.

Research shows there is a connection between your genetic profile and how your hair loss responds to different treatments.

This means that not all hair loss treatments are suitable for everyone, and the success of any treatment depends on your genetic profile and lifestyle factors.

Due to the unique analysis performed by Fagron TrichoTest™, we can determine which hair loss treatments are most likely to give the best results for you.

Fagron TrichoTest™ is intended for use by:

• Anyone who wants to understand how their genetics affect alopecia treatment.
• Patients with a family history of alopecia.
• Men and women who have tried various treatments with little or no success.

Types of alopecia analyzed:

• Androgenetic alopecia
• Alopecia areata
• Telogen effluvium

Fagron TrichoTest™ results are shared only with the prescribing physician through the Fagron Genomics login platform.

The report can be used to select the most appropriate treatment option for the patient, fully tailored to their needs.

The report includes:

• Summary of patient characteristics
• Complete genetic analysis and explanation
• Suggested personalized formulations

After receiving the test results, you will receive a personalized treatment plan that may include:

• Minoxidil – also known as Regaine
• Sillicumax – collagen supplements
• Collagen-stimulating treatments
• Caffeine or Ginkgo – found in caffeine shampoos
• Biotin – also known as Viviscal

Hair loss is a complex condition that is difficult to diagnose because many factors often contribute to its development. Most commonly, hair loss is caused by genetic factors, but other lifestyle factors, such as nutrition, can also play a role.

Early detection of hair loss signs is important for maintaining and protecting existing hair follicles. Creating a personalized treatment plan will help achieve the best results by choosing the most effective treatments.

Research has shown that patients with a combination of two specific genes had more than an 80% chance of experiencing serious complications after filler treatment.